ropivacaine has been researched along with Uterine Cervical Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, L; Cheng, D; Dai, Q; Dai, W; Gu, E; Li, F; Liu, X; Tan, Q; Wei, Z; Xu, G; Yang, Z; Zhang, J; Zhang, L; Zhu, S; Zuo, Y | 1 |
| Chen, X; Guo, X; Huang, S; Liu, W; Song, X | 1 |
| Harrison, GR | 1 |
3 other study(ies) available for ropivacaine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain relief.
Topics: Anesthetics, Local; Animals; Autophagy; Caloric Restriction; Cancer Pain; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Female; Humans; Liposomes; Male; Melanoma; Mice; Mice, Inbred C57BL; Ropivacaine; Sciatic Nerve; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2020 |
Ropivacaine inhibits cervical cancer cell growth via suppression of the miR‑96/MEG2/pSTAT3 axis.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Phosphorylation; Protein Tyrosine Phosphatases, Non-Receptor; Ropivacaine; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation; Uterine Cervical Neoplasms | 2020 |
The use of epidural ropivacaine in high doses for the management of pain from invasive carcinoma of the cervix.
Topics: Adult; Amides; Analgesia, Epidural; Analgesia, Patient-Controlled; Anesthetics, Local; Female; Humans; Pain, Intractable; Palliative Care; Ropivacaine; Uterine Cervical Neoplasms | 1999 |